Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding

Journal of Medicinal Chemistry

Volumn 49, Issue 12, 2006, Pages 3636-3644

  Vig, Balvinder S ^a   Stouch, Terry R ^a,b   Timoszyk, Julita K ^a   Quan, Yong ^a   Wall, Doris A ^a   Smith, Ronald L ^a   Faria, Teresa N ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; DIPEPTIDE; PEPTIDE TRANSPORTER 1; TRIPEPTIDE; TRYPTOPHAN; TYROSINE;

ANIMAL CELL; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DEPOLARIZATION; HUMAN; HYDROPHOBICITY; MEMBRANE DEPOLARIZATION; MOLECULAR MODEL; MOLECULAR STABILITY; NONHUMAN; PHARMACOPHORE; PROTEIN BINDING; PROTEIN TRANSPORT;

ANIMALS; BINDING SITES; BIOLOGICAL TRANSPORT; CELL LINE; DIPEPTIDES; DOGS; ELECTRICITY; HYDROPHOBICITY; MODELS, MOLECULAR; PROLINE; PROTEIN BINDING; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; SYMPORTERS;

EID: 33745134044     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0511029     Document Type: Article

References (46)

1. Rubio-Aliaga, I.; Daniel, H. Mammalian Peptide Transporters as Targets for Drug Delivery. Trends Pharmacol. Sci. 2002, 23, 434-440.
2. Nielsen, C. U.; Brodin, B.; Jorgensen, F. S.; Frokjaer, S.; Steffansen, B. Human Peptide Transporters: Therapeutic Applications. Expert Opin. Ther. Pat. 2002, 12, 1329-1350.
3. Herrera-Ruiz, D.; Knipp, G. T. Current Perspectives on Established and Putative Mammalian Oligopeptide Transporters. J. Pharm. Sci. 2003, 92, 691-714.
4. Daniel, H.; Morse, E. L.; Adibi, S. A. The High and Low Affinity Transport Systems for Dipeptides in Kidney Brush Border Membrane Respond Differently to Alterations in pH Gradient and Membrane Potential. J. Biol. Chem. 1991, 266, 19917-19924.
5. Liang, R.; Fei, Y. J.; Prasad, P. D.; Ramamoorthy S.; Han, H.; Yang-Feng, T. L.; Hediger, M. A.; Ganapathy, V.; Leibach, F. H. Human Intestinal H+/Peptide Cotransporter. Cloning, Functional Expression, and Chromosomal Localization. J. Biol. Chem. 1995, 270, 6456-6463.
6. Kottra, G.; Daniel, H. Bidirectional Electrogenic Transport of Peptides by the Proton-Coupled Carrier Pept1 in Xenopus Laevis Oocytes: Its Asymmetry and Symmetry. J. Physiol. (London, U.K.) 2001, 536, 495-503.
7. Fei, Y. J.; Ganapathy, V.; Leibach, F. H. Molecular and Structural Features of the Proton-Coupled Oligopeptide Transporter Superfamily. Prog. Nucleic Acid Res. Mol. Biol. 1998, 58, 239-261.
8. Bookman, D. E.; Ganapathy, V.; Oblak, T. G.; Leibach, F. H. Localization of Peptide Transporter in Nuclei and Lysosomes of the Pancreas. Int. J. Pancreatol. 1997, 22, 221-225.
9. Knutter, I.; Rubio-Aliaga, I.; Boll, M.; Hause, G.; Daniel, H.; Neubert, K.; Brandsch, M. H+-Peptide Cotransport in the Human Bile Duct Epithelium Cell Line Sk-Cha-1. Am. J. Physiol. 2002, 283, G222-229.
10. Shen, H.; Smith, D. E.; Yang, T.; Huang, Y. G.; Schnermann, J. B.; Brosius, F. C., 3rd Localization of Pept1 and Pept2 Proton-Coupled Oligopeptide Transporter Mrna and Protein in Rat Kidney. Am. J. Physiol 1999, 276, F658-665.
11. Abramson, J.; Smirnova, I.; Kasho, V.; Verner, G.; Kaback, H. R.; Iwata, S. Structure and Mechanism of the Lactose Permease of Escherichia coli. Science 2003, 301, 610-615.
12. Nussberger, S.; Steel, A.; Trotti, D.; Romero, M. F.; Boron, W. F.; Hediger, M. A. Symmetry of H+ Binding to the Intra- and Extracellular Side of the H+-Coupled Oligopeptide Cotransporter Pept1. J. Biol. Chem. 1997, 272, 7777-7785.
13. Bailey, P. D.; Boyd, C. A.; Bronk, J. R.; Collier, I. D.; Meredith, D.; Morgan, K. M.; Temple, C. S. How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter Pept1. Angew Chem., Int. Ed. 2000, 39, 505-508.
14. Biegel, A.; Gebauer, S.; Hartrodt, B.; Brandsch, M.; Neubert, K.; Thondorf, I. Three-Dimensional Quantitative Structure-Activity Relationship Analyses of Beta-Lactam Antibiotics and Tripeptides as Substrates of the Mammalian H+/Peptide Cotransporter Pept1. J. Med. Chem. 2005, 48, 4410-4419.
15. Vabeno, J.; Nielsen, C. U.; Steffansen, B.; Lejon, T.; Sylte, I.; Jorgensen, F. S.; Luthman, K. Conformational Restrictions in Ligand Binding to the Human Intestinal Di-/Tripeptide Transporter: Implications for Design of Hpept1 Targeted Prodrugs. Bioorg. Med. Chem. 2005, 13, 1977-1988.
16. Gebauer, S.; Knutter, I.; Hartrodt, B.; Brandsch, M.; Neubert, K.; Thondorf, I. Three-Dimensional Quantitative Structure-Activity Relationship Analyses of Peptide Substrates of the Mammalian H+/Peptide Cotransporter Pept1. J. Med. Chem. 2003, 46, 5725-5734.
17. Daniel, H.; Kottra, G. The Proton Oligopeptide Cotransporter Family Slc15 in Physiology and Pharmacology. Pflugers Arch. 2004, 447, 610-618.
18. Temple, C. S.; Stewart, A. K.; Meredith, D.; Lister, N. A.; Morgan, K. M.; Collier, I. D.; Vaughan-Jones, R. D.; Boyd, C. A.; Bailey, P. D.; Bronk, J. R. Peptide Mimics as Substrates for the Intestinal Peptide Transporter. J. Biol. Chem. 1998, 273, 20-22.
19. During, F.; Will, J.; Amasheh, S.; Clauss, W.; Ahlbrecht, H.; Daniel, H. Minimal Molecular Determinants of Substrates for Recognition by the Intestinal Peptide Transporter. J. Biol. Chem. 1998, 273, 23211-23218.
20. Brandsch, M.; Thunecke, F.; Kullertz, G.; Schutkowski, M.; Fischer, G.; Neubert, K. Evidence for the Absolute Conformational Specificity of the Intestinal H+/Peptide Symporter, Pept1. J. Biol. Chem. 1998, 273, 3861-3864.
21. Vabeno, J.; Lejon, T.; Nielsen, C. U.; Steffansen, B.; Chen, W.; Ouyang, H.; Borchardt, R. T.; Luthman, K. Phe-Gly Dipeptidomimetics Designed for the Di-/Tripeptide Transporters Pept1 and Pept2: Synthesis and Biological Investigations. J. Med. Chem. 2004, 47, 1060-1069.
22. Borner, V.; Fei, Y. J.; Hartrodt, B.; Ganapathy, V.; Leibach, F. H.; Neubert, K.; Brandsch, M. Transport of Amino Acid Aryl Amides by the Intestinal H+/Peptide Cotransport System, Pept1. Eur. J. Biochem. 1998, 255, 698-702.
23. Fujita, T.; Morishita, Y.; Ito, H.; Kuribayashi, D.; Yamamoto, A.; Muranishi, S. Enhancement of the Small Intestinal Uptake of Phenylalanylglycine Via a H+/Oligopeptide Transport System by Chemical Modification with Fatty Acids. Life Sci. 1997, 61, 2455-2465.
24. Brandsch, M.; Knutter, I.; Thunecke, F.; Hartrodt, B.; Born, I.; Borner, V.; Hirche, F.; Fischer, G.; Neubert, K. Decisive Structural Determinants for the Interaction of Proline Derivatives with the Intestinal H+/Peptide Symporter. Eur. J. Biochem. 1999, 266, 502-508.
25. Meredith, D.; Temple, C. S.; Guha, N.; Sword, C. J.; Boyd, C. A.; Collier, I. D.; Morgan, K. M.; Bailey, P. D. Modified Amino Acids and Peptides as Substrates for the Intestinal Peptide Transporter Pept1. Eur. J. Biochem. 2000, 267, 3723-3728.
26. Hidalgo, I. J.; Bhatnagar, P.; Lee, C. P.; Miller, J.; Cucullino, G.; Smith, P. L. Structural Requirements for Interaction with the Oligopeptide Transporter in Caco-2 Cells. Pharm. Res. 1995, 12, 317-319.
27. Tamura, K.; Lee, C. P.; Smith, P. L.; Borchardt, R. T. Metabolism, Uptake, and Transepithelial Transport of the Stereoisomers of Val-Val-Val in the Human Intestinal Cell Line, Caco-2. Pharm. Res. 1996, 13, 1663-1667.
28. Sawada, K.; Terada, T.; Saito, H.; Hashimoto, Y.; Inui, K. I. Recognition of L-Amino Acid Ester Compounds by Rat Peptide Transporters Pept1 and Pept2. J. Pharmacol. Exp. Ther. 1999, 291, 705-709.
29. Terada, T.; Sawada, K.; Irie, M.; Saito, H.; Hashimoto, Y.; Inui, K. Structural Requirements for Determining the Substrate Affinity of Peptide Transporters Pept1 and Pept2. Pflugers Arch. 2000, 440, 679-684.
30. Tateoka, R.; Abe, H.; Miyauchi, S.; Shuto, S.; Matsuda, A.; Kobayashi, M.; Miyazaki, K.; Kamo, N. Significance of Substrate Hydrophobicity for Recognition by an Oligopeptide Transporter (Pept1). Bioconjugale Chem. 2001, 12, 485-492.
31. Knutter, I.; Hartrodt, B.; Theis, S.; Foltz, M.; Rastetter, M.; Daniel, H.; Neubert, K.; Brandsch, M. Analysis of the Transport Properties of Side Chain Modified Dipeptides at the Mammalian Peptide Transporter Pept1. Eur. J. Pharm. Sci. 2004, 21, 61-67.
32. Swaan, P. W.; Tukker, J. J. Molecular Determinants of Recognition for the Intestinal Peptide Carrier. J. Pharm. Sci. 1997, 86, 596-602.
33. Swaan, P. W.; Koops, B. C.; Moret, E. E.; Tukker, J. J. Mapping the Binding Site of the Small Intestinal Peptide Carrier (Pept1) Using Comparative Molecular Field Analysis. Recept. Channels 1998, 6, 189-200.
34. Faria, T. N.; Timoszyk, J. K.; Slouch, T.; Vig, B. S.; Amidon, G. L.; Weaver, C. D.; Wall, D. A.; Smith, R. A Novel High Throughput Pept1 Transporter Assay Differentiates between Substrates and Antagonists. Mol. Pharm. 2004, 1, 67-76.
35. Herrera-Ruiz, D.; Faria, T.; Bhardwaj, R.; Timoszyk, J.; Gudmundsson, O.; Moench, P.; Wall, D.; Smith, R.; Knipp, G. A Novel Hpept1-Stably Transfected Cell Line: Establishing a Correlation between Expression and Function. Mol. Pharm. 2004, 1, 136-144.
36. Karplus, P. A. Hydrophobicity Regained. Protein Sci. 1997, 6, 1302-1307.
37. Zamyatnin, A. A. Protein Volume in Solution. Prog. Biophys. Mol. Biol. 1972, 24, 107-123.
38. Dalgaard, P. Introductory Statistics with R; 1st ed.; Springer: Berlin, Germany, 2002; pp 1-288.
39. Nielsen, C. U.; Vabeno, J.; Andersen, R.; Brodin, B.; Steffansen, B. Recent Advances in Therapeutic Applications of Peptide Transporters. Expert. Opin. Ther. Pat. 2005, 15, 153-166.
40. Brandsch, M.; Knutter, I.; Leibach, F. H. The Intestinal H+/Peptide Symporter Pept1: Structure-Affinity Relationships. Eur. J. Pharm. Sci. 2004, 21, 53-60.
41. Doring, F.; Walter, J.; Will, J.; Focking, M.; Boll, M.; Amasheh, S.; Clauss, W.; Daniel, H. Delta-Aminolevulinic Acid Transport by Intestinal and Renal Peptide Transporters and Its Physiological and Clinical Implications. J. Clin. Invest. 1998, 101, 2761-2767.
42. Meredith, D.; Boyd, C. A.; Bronk, J. R.; Bailey, P. D.; Morgan, K. M.; Collier, I. D.; Temple, C. S. 4-Aminomethylbenzoic Acid Is a Non-Translocated Competitive Inhibitor of the Epithelial Peptide Transporter Pept1. J. Physiol. (London, U.K.) 1998, 512, 629-634.
43. Song, X.; Lorenzi, P. L.; Landowski, C. P.; Vig, B. S.; Hilfinger, J. M.; Amidon, G. L. Amino Acid Ester Prodrugs of the Anticancer Agent Gemcitabine: Synthesis. Bioconversion, Metabolic Bioevasion, and Hpept1-Mediated Transport. Mol. Pharm. 2005, 2, 157-167.
44. Li, J.; Hidalgo, I. J. Molecular Modeling Study of Structural Requirements for the Oligopeptide Transporter. J. Drug Targeting 1996, 4, 9-17.
45. Yeung, A. K.; Basu, S. K.; Wu, S. K.; Chu, C.; Okamoto, C. T.; Hamm-Alvarez, S. F.; von Grafenstein, H.; Shen, W. C.; Kim, K. J.; Bolger, M. B.; Haworth, I. S.; Ann, D. K.; Lee, V. H. Molecular Identification of a Role for Tyrosine 167 in the Function of the Human Intestinal Proton- Coupled Dipeptide Transporter (Hpept1). Biochem. Biophys. Res. Commun. 1998, 250, 103-107.
46. Bolger, M. B.; Haworth, I. S.; Yeung, A. K.; Ann, D.; von Gratenstein, H.; Hamm-Alvarez, S.; Okamoto, C. T.; Kim, K. J.; Basum S. K.; Wu, S.; Lee, V. H. Structure. Function, and Molecular Modeling Approaches to the Study of the Intestinal Dipeptide Transporter Pept1. J. Pharm. Sci. 1998, 87, 1286-1291.